🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Ruella will be speaking at the Advances in Adoptive Cell Therapies sponsored by BD Sciences! See link below for more information on the fantastic line up! ↓↓↓ workcast.com/register?cpak=…

This review by guru puneeth, Marco Ruella et al. Ruella Lab Penn Medicine examines how single-cell RNA sequencing has transformed the understanding of basic #cancer and immune biology in the context of cancer #immunotherapy. bit.ly/3mslYtT #JEMCancerFocus

Our latest review on single-cell RNAseq in immunotherapy is out in Journal of Experimental Medicine! Thanks for this Herculean endeavour to guru puneeth and Ruella Lab Penn Medicine @Penn_IFI

Our letter to the NEJM reporting the five-year outcomes of CART19 (CTL019, now called tisagenlecleucel) in lymphoma patients is out! Thanks to Drs. Schuster, Chong and Penn Medicine Penn Medicine - Abramson Cancer Center @Penn_IFI Carl June Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 nejm.org/doi/full/10.10…

.guru puneeth et al. Ruella Lab discuss the current landscape of single-cell transcriptomics for cancer #immunotherapy. bit.ly/3mslYtT From our Cancer Immunotherapy collection to accompany #SITC21 👉 bit.ly/3H5wvXl